Disc Medicine, Inc. (NASDAQ:IRON – Free Report) – Investment analysts at Leerink Partnrs reduced their Q1 2024 EPS estimates for shares of Disc Medicine in a note issued to investors on Thursday, March 21st. Leerink Partnrs analyst T. Smith now anticipates that the company will earn ($1.10) per share for the quarter, down from their […]
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,320,000 shares, an increase of 7.3% from the January 15th total of 1,230,000 shares. Based on an average daily volume of 251,800 shares, […]
Disc Medicine, Inc (NASDAQ:IRON) Receives $64 56 Consensus PT from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Disc Medicine, Inc (NASDAQ:IRON) Given Consensus Recommendation of Buy by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Disc Medicine Opco Inc (NASDAQ:IRON – Get Free Report) Director Kevin Bitterman sold 72,931 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $52.40, for a total value of $3,821,584.40. Following the transaction, the director now directly owns 882,224 shares in […]